Raymond James Financial Inc. Acquires New Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Raymond James Financial Inc. bought a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 1,038,053 shares of the pharmacy operator's stock, valued at approximately $9,685,000. Raymond James Financial Inc. owned 0.12% of Walgreens Boots Alliance at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in WBA. Quest Partners LLC boosted its position in shares of Walgreens Boots Alliance by 379.4% during the third quarter. Quest Partners LLC now owns 10,499 shares of the pharmacy operator's stock worth $94,000 after buying an additional 8,309 shares during the period. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in Walgreens Boots Alliance during the 3rd quarter worth $149,000. PNC Financial Services Group Inc. grew its stake in shares of Walgreens Boots Alliance by 23.4% in the third quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator's stock worth $3,050,000 after purchasing an additional 64,586 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Walgreens Boots Alliance during the third quarter valued at $3,448,000. Finally, Intech Investment Management LLC bought a new stake in shares of Walgreens Boots Alliance during the third quarter valued at about $109,000. 58.59% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

WBA has been the topic of several research analyst reports. Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Evercore ISI raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a research note on Monday, January 13th. Truist Financial cut their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research report on Friday, January 31st. Bank of America lifted their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research report on Monday, January 13th. Finally, StockNews.com started coverage on Walgreens Boots Alliance in a report on Tuesday, March 18th. They issued a "hold" rating for the company. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of "Hold" and an average target price of $10.59.

Remove Ads

Walgreens Boots Alliance Trading Down 0.3 %

WBA stock traded down $0.03 during mid-day trading on Tuesday, reaching $11.12. 7,767,058 shares of the stock traded hands, compared to its average volume of 20,772,329. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.05. The stock's fifty day moving average is $10.94 and its 200-day moving average is $9.85. The company has a market cap of $9.61 billion, a P/E ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter in the prior year, the firm earned $0.66 EPS. The firm's quarterly revenue was up 7.6% on a year-over-year basis. As a group, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.